The Alabama Department of Public Health says a person who received the Pfizer coronavirus vaccine at Decatur Morgan Hospital suffered a severe allergic reaction.

"Remember no one's ever taken COVID-19 vaccine until recently so we would not know if they had a history of allergy to COVID-19 vaccine because again this is the first time we have ever administered this in the United states, but if you have a previous history of anaphylaxis to another biological, this is what is categized as a precaution and by that persons need to be aware that there is a potential risk of allergic reaction," said Dr. Karen Landers, with the Alabama Department of Public Health.

The person was treated with anaphylaxis protocol, according to the department.

"Also ensure that persons understand that if they have no history of allergic reaction, they need to be monitored for 15 minutes after administration but 30 minutes if they have a history of anaphylaxis reaction to other biologicals" said Dr. Karen Landers, with the Alabama Department of Public Health.

No other information about the person has been released.

"It's very rare with vaccines but it can happen and we do know that it has been reported in very small numbers" said Dr. Karen Landers, with the Alabama Department of Public Health.

Stay with WAAY 31 for updates.

Here’s the full news release from the department:

The Alabama Department of Public Health (ADPH) has been made aware that a person who received the Pfizer BioNTech COVID-19 vaccine Tuesday experienced anaphylaxis (a severe allergic reaction) several minutes after taking the vaccine and while in required post-vaccine observation.

The patient was immediately treated with anaphylaxis protocol at Decatur Morgan Hospital where the vaccine was administered.

At this time, the patient is stable and appears to be recovering. Information received is that the patient had a previous history of anaphylaxis to biologic agents and, following risk assessment, wished to proceed with vaccine. Previous anaphylaxis to biologics is a precaution, not a contraindication, to COVID-19 vaccine.

As required by the emergency use authorization (EUA) the adverse reaction has been documented and reported to the manufacturer.

As of Wednesday at 7 a.m., Alabama providers reported 15,286 doses of COVID-10 vaccine had been administered in the state. Nationwide, six persons have been reported to have had anaphylaxis after COVID-19 vaccine.

This is the only notice that ADPH has received of any allergic reactions in Alabama. ADPH extends its wishes for a quick recovery to the patient, family and all involved.